Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adnan Delic"'
Autor:
Samed Djedovic, Sevleta Avdic, Azra Avdic-Salihovic, Miodrag Ostojic, Nedzad Kadric, Enes Osmanovic, Amar Terzic, Adnan Delic
Publikováno v:
Medical Archives
Introduction Postoperative Atrial Fibrillation (POAF) is associated with a higher rate of postoperative complications and mortality, as well as with longer hospitalization and increased treatment costs. We have designed and performed a randomized, tr
Autor:
Enes Abdović, Elnur Smajić, Zlatko Midzić, Amila Arslanagić, Fahir Baraković, Hajro Basić, Milenko Krneta, Radenko Celik, Zumreta Kusljugic, Emir Fazlibegovic, Katarina Divković, Mustafa Hadziomerovic, Nedzad Keco, Amra Macić-Dzanković, Bajro Avdić, Adnan Delic, Hajra Boskailo
Publikováno v:
Bosn J Basic Med Sci
Bosnian Journal of Basic Medical Sciences, Vol 5, Iss 1 (2005)
Bosnian Journal of Basic Medical Sciences, Vol 5, Iss 1 (2005)
Hypertension is a major risk factor for cardiovascular diseases; drugs that reduce blood pressure and simultaneously improve or reverse endothelian dysfunction, as nebivolol, may be advantageous in terms of cardiovascular protection. The objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebb67a19568b73ad7d9a04c538a02b9
https://europepmc.org/articles/PMC7214063/
https://europepmc.org/articles/PMC7214063/
Publikováno v:
Cardiologia Croatica. 8:285-285
Cardiologia CROATICA Objectives: The aim of this article is to investigate the relationship between the degree of the common carotid artery (CCA) atherosclerosis and the degree of complexity of the coronary artery disease (CAD) expressed with SYNTAX
Autor:
Zumreta Kušljugić, Katarina Divković, Fahir Baraković, Elnur Smajić, Amila Arslanagić, Mustafa Hadžiomerović, Emir Fazlibegović, Zlatico Midžić, Enes Abdović, Milenko Krneta, Radenko Čelik, Hajro Bašić, Bajro Avdić, Adnan Delić, Amra Macić-Džanković, Nedžad Kečo, Hajra Boškailo
Publikováno v:
Biomolecules & Biomedicine, Vol 5, Iss 1 (2005)
Hypertension is a major risk factor for cardiovascular diseases; drugs that reduce blood pressure and simultaneously improve or reverse endothelian dysfunction, as nebivolol, may be advantageous in terms of cardiovascular protection. The objective of
Externí odkaz:
https://doaj.org/article/ebfef610994243cc90d28e7a5b8d47c5